← Back to Patent Explorer
US5955331A Expired / Lapsed US ⏱️ 0.0 years remaining

Recombinant retroviruses with amphotropic and ecotropic host ranges

Assignee: Whitehead Institute for Biomedical Research
•
Filing: 1995-06-07
•
Granted: 1999-09-21
•
Expires: 2015-06-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Packaging cell lines useful for the generation of helper-free recombinant retroviruses with amphotropic or ecotropic host ranges, methods of constructing such packaging cell lines and methods of using the recombinant retroviruses to introduce DNA of interest into eukaryotic cells, both in vitro and in vivo.

Inventors

  • 👤 Olivier Danos
  • 👤 Richard C. Mulligan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 15:27
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/85; C12N15/86; C07; C07K; C07K14/00; C07K14/005; C12N7/00; C12N2740/00; C12N2740/00011; C12N2740/10011; C12N2740/13011; C12N2740/13022; C12N2740/13041; C12N2740/13043; C12N2740/13045; C12N2740/13051; C12N2740/13052

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 91 words
A stable retroviral packaging cell line which generates helper-free recombinant retrovirus with an amphotropic host range, said stable retroviral packaging cell line comprising packaging cells, wherein the retrovirally derived component of said packaging cells' genome comprises stably incorporated first and second replication-defective retroviral constructs, wherein said first and second replication-defective retroviral constructs: 1) encode and express mutually exclusive regions of the gag, pol, and env genes; 2) were separately and sequentially introduced into the genome of said packaging cells; and wherein the incorporated env gene is derived from an amphotropic virus.
Claim 2
Dependent Claim 91 words
A stable retroviral packaging cell line which generates helper-free recombinant retrovirus with an amphotropic host range, said stable retroviral packaging cell line comprising packaging cells, wherein the retrovirally derived component of said packaging cells' genome comprises stably incorporated first and second replication-defective retroviral constructs, wherein said first and second replication-defective retroviral constructs: 1) encode and express mutually exclusive regions of the gag, pol, and env genes; 2) were separately and sequentially introduced into the genome of said packaging cells; and wherein the incorporated env gene is derived from an amphotropic virus.
Claim 3
Dependent Claim 121 words
A stable retroviral packaging cell line according to claim 1 wherein: a) the genome of the first replication-defective retroviral construct comprises: 1) a defective Psi packaging region; 2) a functional form of at least one of the group consisting of gag and pol; 3) a defective env region; and b) the genome of the second replication-defective retroviral construct comprises: 1) a defective Psi packaging region; 2) a functional amphotropic env gene; and 3) defective gag and/or pol regions which corresponds to the gag and/or pol regions which are not defective in the first retroviral construct, wherein said sequential introduction into the genome of said packaging cells results in the expression of complete but physically separated gag, pol and env coding regions.
Claim 4
Dependent Claim 39 words
A packaging cell line according to claim 2 wherein said first and second replication-defective retroviral constructs additionally comprise 3' LTR sequences, and wherein there is a deletion in the 3' LTR sequence of said first or second retroviral construct.
Claim 5
Dependent Claim 39 words
A packaging cell line according to claim 2 wherein said first and second replication-defective retroviral constructs additionally comprise 3' LTR sequences, and wherein there are deletions in the 3' LTR sequences of said first and second replication-defective retroviral constructs.
Claim 6
Dependent Claim 19 words
A packaging cell line according to claim 3 or 4 wherein said deletions remove the entire 3' LTR sequence.
Claim 7
Dependent Claim 18 words
A packaging cell line according to claim 3 or 4 wherein the first replication-defective retroviral construct is pCRIPenv.
Claim 8
Dependent Claim 18 words
A packaging cell line according to claim 3 or 4 wherein the second replication-defective retroviral construct is pCRIPAMgag.
Claim 9
Independent Claim 30 words
A method of using the packaging cell line according to any one of claims 1, 2, 3, or 4, comprising the step of producing amphotropic retrovirus in said cell line.
Claim 10
Dependent Claim 22 words
A method of using the packaging cell line of claim 5 comprising the step of producing amphotropic retrovirus in said cell line.
Claim 11
Dependent Claim 22 words
A method of using the packaging cell line of claim 6 comprising the step of producing amphotropic retrovirus in said cell line.
Claim 12
Dependent Claim 22 words
A method of using the packaging cell line of claim 7 comprising the step of producing amphotropic retrovirus in said cell line.
Claim 13
Independent Claim 197 words
A method of making a stable retroviral packaging cell line which generates helper-free recombinant retrovirus with an amphotropic host range, comprising the steps of: a) transfecting mammalian host cells with a first replication-defective retroviral construct, the genome of which comprises: i) sequences derived from the 5' and 3' LTRs of a first retrovirus of interest; (ii) a defective Psi packaging region; (iii) a functional form of at least one region selected from the group consisting of gag and pol; (iv) a defective env region; and (v) a eucaryotic promoter for expressing the functional retroviral genes; b) culturing the transfected cells of step a); c) transfecting the cells cultured in step b) with a second replication-defective retroviral construct, the genome of which comprises: (i) sequences derived from the 5' and 3' LTRs of a second retrovirus of interest; (ii) a defective Psi packaging region; (iii) a functional amphotropic env gene; (iv) defective gag and/or pol regions which corresponds to the gag and/or pol regions which are not defective in the first retroviral construct; and d) culturing the cells transfected in step c) whereby a packaging cell comprising complete but physically separated gag/pol and env coding regions is produced.
Claim 14
Independent Claim 197 words
A method of making a stable retroviral packaging cell line which generates helper-free recombinant retrovirus with an amphotropic host range, comprising the steps of: a) transfecting mammalian host cells with a first replication-defective retroviral construct, the genome of which comprises: i) sequences derived from the 5' and 3' LTRs of a first retrovirus of interest; (ii) a defective Psi packaging region; (iii) a functional form of at least one region selected from the group consisting of gag and pol; (iv) a defective env region; and (v) a eucaryotic promoter for expressing the functional retroviral genes; b) culturing the transfected cells of step a); c) transfecting the cells cultured in step b) with a second replication-defective retroviral construct, the genome of which comprises: (i) sequences derived from the 5' and 3' LTRs of a second retrovirus of interest; (ii) a defective Psi packaging region; (iii) a functional amphotropic env gene; (iv) defective gag and/or pol regions which corresponds to the gag and/or pol regions which are not defective in the first retroviral construct; and d) culturing the cells transfected in step c) whereby a packaging cell comprising complete but physically separated gag/pol and env coding regions is produced.
Claim 15
Dependent Claim 38 words
A method according to claim 12 wherein said first and second replication-defective retroviral constructs additionally comprise 3' LTR sequences, and wherein there is a deletion in the 3' LTR sequence of said first or second replication-defective retroviral constructs.
Claim 16
Dependent Claim 37 words
A method according to claim 12 wherein said fist and second replication-defective retroviral constructs additionally comprise 3' LTR sequences, and wherein there are deletions in the 3' LTR sequences of said first and second replication-defective retroviral constructs.
Claim 17
Dependent Claim 17 words
A method according to claim 12 or 14 wherein said deletions remove the entire 3' LTR sequence.
Claim 18
Dependent Claim 16 words
A method according to claim 13 or 14 wherein the first replication-defective retroviral construct is pCRIPenv.
Claim 19
Dependent Claim 16 words
A method according to claim 13 or 14 wherein the second replication-defective retroviral construct is pCRIPAMgag.

References Cited (Backward Citations)

US4650764A Cited
DE3636287A1 Cited
WO1989007136A2 Cited
US5278056A Cited
WO1990002806A1 Cited
US5449614A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-09-20 2003-03-22 2003-09-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-09-20 2007-03-22 2007-09-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-09-20 2011-03-22 2011-09-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag